Hidetoh Toki

610 total citations
11 papers, 494 citations indexed

About

Hidetoh Toki is a scholar working on Pharmacology, Biological Psychiatry and Pathology and Forensic Medicine. According to data from OpenAlex, Hidetoh Toki has authored 11 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 7 papers in Biological Psychiatry and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Hidetoh Toki's work include Tryptophan and brain disorders (7 papers), Treatment of Major Depression (7 papers) and Stress Responses and Cortisol (2 papers). Hidetoh Toki is often cited by papers focused on Tryptophan and brain disorders (7 papers), Treatment of Major Depression (7 papers) and Stress Responses and Cortisol (2 papers). Hidetoh Toki collaborates with scholars based in Japan, India and China. Hidetoh Toki's co-authors include Junichi Yamaguchi, Kenji Hashimoto, Shigeyuki Chaki, Michihiko Iijima, Kenichi Fukumoto, Takashi Hashihayata, Youge Qu, Chun Yang, Takuya Ichikawa and Hiroyuki Koike and has published in prestigious journals such as Biological Psychiatry, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Hidetoh Toki

10 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hidetoh Toki Japan 7 389 367 183 89 49 11 494
Swarajya Lakshmi Vattem Venkata United States 8 431 1.1× 333 0.9× 196 1.1× 47 0.5× 110 2.2× 11 625
Rejish K. Thomas Canada 6 185 0.5× 176 0.5× 112 0.6× 40 0.4× 97 2.0× 7 463
Michael P. Clay United States 8 132 0.3× 152 0.4× 315 1.7× 97 1.1× 156 3.2× 11 553
June Watzl United States 7 167 0.4× 152 0.4× 156 0.9× 20 0.2× 37 0.8× 7 435
Małgorzata Wolak Poland 10 66 0.2× 124 0.3× 112 0.6× 64 0.7× 110 2.2× 19 394
Bryan Baker United States 5 309 0.8× 234 0.6× 301 1.6× 39 0.4× 88 1.8× 6 516
Thangaraj Devadoss India 16 94 0.2× 170 0.5× 149 0.8× 134 1.5× 186 3.8× 38 616
Natacha Vanattou‐Saïfoudine United Kingdom 9 103 0.3× 192 0.5× 123 0.7× 83 0.9× 149 3.0× 12 441
Anne B. Need United States 11 119 0.3× 77 0.2× 316 1.7× 33 0.4× 237 4.8× 15 529
Erin M. MacKenzie Canada 12 90 0.2× 83 0.2× 108 0.6× 40 0.4× 122 2.5× 26 411

Countries citing papers authored by Hidetoh Toki

Since Specialization
Citations

This map shows the geographic impact of Hidetoh Toki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetoh Toki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetoh Toki more than expected).

Fields of papers citing papers by Hidetoh Toki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidetoh Toki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetoh Toki. The network helps show where Hidetoh Toki may publish in the future.

Co-authorship network of co-authors of Hidetoh Toki

This figure shows the co-authorship network connecting the top 25 collaborators of Hidetoh Toki. A scholar is included among the top collaborators of Hidetoh Toki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidetoh Toki. Hidetoh Toki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Toki, Hidetoh, et al.. (2024). Preclinical metabolism and the disposition of vornorexant/TS‐142, a novel dual orexin 1/2 receptor antagonist for the treatment of insomnia. Pharmacology Research & Perspectives. 12(2). e1183–e1183. 4 indexed citations
2.
Kobayashi, Yuki, et al.. (2023). Lead generation from N-[benzyl(4-phenylbutyl)carbamoyl]amino acid as a novel LPA1 antagonist for the treatment of systemic sclerosis. European Journal of Medicinal Chemistry. 260. 115749–115749.
3.
Toki, Hidetoh, et al.. (2022). Chiral LC-MS/MS method for the simultaneous determination of (R,S)-ketamine, (R,S)-norketamine, and (2R,6R;2S,6S)-hydroxynorketamine in mouse plasma and brain. Journal of Pharmaceutical and Biomedical Analysis. 224. 115168–115168. 5 indexed citations
4.
5.
Zhang, Kai, Hidetoh Toki, Yūkō Fujita, et al.. (2018). Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model. Psychopharmacology. 235(11). 3177–3185. 27 indexed citations
6.
Yang, Chun, Shizuka Kobayashi, Kazuhito Nakao, et al.. (2018). AMPA Receptor Activation–Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine. Biological Psychiatry. 84(8). 591–600. 97 indexed citations
7.
Chang, Lijia, Hidetoh Toki, Youge Qu, et al.. (2018). No Sex-Specific Differences in the Acute Antidepressant Actions of (R)-Ketamine in an Inflammation Model. The International Journal of Neuropsychopharmacology. 21(10). 932–937. 24 indexed citations
8.
Yamaguchi, Junichi, Hidetoh Toki, Youge Qu, et al.. (2018). (2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice. Neuropsychopharmacology. 43(9). 1900–1907. 81 indexed citations
9.
Fukumoto, Kenichi, Hidetoh Toki, Michihiko Iijima, et al.. (2017). Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine. Journal of Pharmacology and Experimental Therapeutics. 361(1). 9–16. 200 indexed citations
10.
11.
Sakamoto, Shinichi, Keiko Miyoshi, Hiroshi Urayama, et al.. (1991). [Serum monitoring of methotrexate (MTX) and 7-hydroxymethotrexate concentrations in patients treated with MTX using high-pressure liquid chromatography (HPLC) and comparison of serum MTX levels between HPLC method and fluorescence polarization immunoassay (FPIA)].. PubMed. 18(7). 1119–25. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Swarajya Lakshmi Vattem Venkata Breakdown of academic impact, for papers by Rejish K. Thomas Breakdown of academic impact, for papers by Michael P. Clay Breakdown of academic impact, for papers by June Watzl Breakdown of academic impact, for papers by Małgorzata Wolak Breakdown of academic impact, for papers by Bryan Baker Breakdown of academic impact, for papers by Thangaraj Devadoss Breakdown of academic impact, for papers by Natacha Vanattou‐Saïfoudine Breakdown of academic impact, for papers by Anne B. Need Breakdown of academic impact, for papers by Erin M. MacKenzie
Rankless by CCL
2026